Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
人工熊胆粉替代熊胆粉的熊胆胶囊治疗急性咽炎肝胃郁热证区组随机、双盲、多中心等效性临床研究
[Translation] A randomized, double-blind, multi-center equivalence clinical study on the treatment of acute pharyngitis with liver-stomach stagnation-heat syndrome by artificial bear bile powder instead of bear bile powder with Xiongdan capsules
探索性试验:初步对比人工熊胆粉替代熊胆粉的熊胆胶囊治疗急性咽
炎(肝胃郁热证)的有效性、安全性、合适剂量,为确证性试验设计
提供参考。
[Translation] Exploratory trial: Preliminary comparison of artificial bear bile powder to replace bear bile powder with bear bile capsules in the treatment of acute pharyngeal
Efficacy, safety, and appropriate dose of inflammation (liver-stomach stagnation-heat syndrome), designed for a confirmatory trial
for reference.
人工熊胆粉替代熊胆粉的熊胆胶囊治疗急性结膜炎(肝经火热证)区组随机、双盲、多中心等效性临床研究
[Translation] A randomized, double-blind, multi-center equivalence clinical study on the treatment of acute conjunctivitis (liver meridian fire syndrome) with artificial bear bile powder instead of bear bile powder with Xiongdan capsules
初步对比人工熊胆粉替代熊胆粉的熊胆胶囊治疗急性结膜炎(肝经火热证)有效性、安全性、合适剂量,为确证性试验设计提供参考。
[Translation] The efficacy, safety and appropriate dose of artificial bear bile powder instead of bear bile powder for the treatment of acute conjunctivitis (liver meridian fire syndrome) were preliminarily compared to provide reference for the design of confirmatory experiments.
[Translation] Phase I clinical human tolerance test of artificial bear bile powder
以中国健康成年受试者为研究对象,进行人工熊胆粉临床人体耐受性研究,从安全的初始剂量开始,观察人体对该药的耐受性及其产生的不良反应,确定安全耐受的人用剂量,了解在此剂量下的不良反应,为人工熊胆粉的临床应用的安全性提供数据支持。
[Translation] Taking Chinese healthy adult subjects as the research object, the clinical human tolerance study of artificial bear bile powder was carried out. Starting from a safe initial dose, the tolerance of the drug and its adverse reactions were observed, and the safe tolerance was determined. To understand the adverse reactions at this dose for human use, and to provide data support for the safety of the clinical application of artificial bear bile powder.
100 Clinical Results associated with Zhongshan Anshi Biopharmaceutical Co., Ltd.
0 Patents (Medical) associated with Zhongshan Anshi Biopharmaceutical Co., Ltd.
100 Deals associated with Zhongshan Anshi Biopharmaceutical Co., Ltd.
100 Translational Medicine associated with Zhongshan Anshi Biopharmaceutical Co., Ltd.